Table 6.
Calcitonin Cut-Off (pg/mL) |
N with Central LNM |
N without Central LNM |
Positive LR | Negative LR | N with IpsilateralLateral LNM |
N without Ipsilateral Lateral LNM |
Positive LR | Negative LR |
---|---|---|---|---|---|---|---|---|
20 | 2 | 20 | 1.22 (1.10–1.36) | 0.14 (0.03–0.56) | 0 | 22 | 1.26 (1.14–1.38) | 0 |
100 | 3 | 41 | 1.65 (1.38–1.96) | 0.10 (0.03–0.31) | 1 | 43 | 1.64 (1.40–1.91) | 0.04 (0.01–0.29) |
200 | 8 | 54 | 1.98 (1.57–2.50) | 0.20 (0.10–0.40) | 4 | 58 | 2.02 (1.63–2.50) | 0.12 (0.05–0.32) |
300 | 13 | 61 | 2.17 (1.65–2.86) | 0.29 (0.17–0.49) | 7 | 67 | 2.33 (1.81–3.02) | 0.18 (0.09–0.37) |
400 | 23 | 62 | 1.86 (1.37–2.51) | 0.50 (0.35–0.73) | 12 | 73 | 2.53 (1.89–3.40) | 0.27 (0.16–0.45) |
500 | 25 | 67 | 2.07 (1.47–2.89) | 0.51 (0.36–0.72) | 13 | 79 | 2.94 (2.10–4.12) | 0.29 (0.17–0.47) |
1000 | 40 | 76 | 1.98 (1.26–3.10) | 0.72 (0.57–0.90) | 27 | 89 | 3.21 (2.02–5.10) | 0.53 (0.39–0.71) |
2000 | 52 | 82 | 1.71 (0.95–3.05) | 0.86 (0.73–1.02) | 37 | 97 | 3.95 (2.09–7.48) | 0.67 (0.54–0.82) |
3000 | 59 | 88 | 1.78 (0.82–3.81) | 0.91 (0.80–1.04) | 47 | 100 | 3.27 (1.47–7.26) | 0.82 (0.70–0.95) |
5000 | 61 | 91 | 2.16 (0.87–5.25) | 0.91 (0.82–1.02) | 49 | 103 | 4.50 (1.70–12.10) | 0.83 (0.72–0.95) |
7000 | 64 | 92 | 1.82 (0.66–5.00) | 0.95 (0.86–1.04) | 51 | 105 | 6.32 (1.85–22.02) | 0.85 (0.75–0.95) |
10,000 | 68 | 94 | 1.37 (0.35–5.26) | 0.98 (0.92–1.06) | 56 | 106 | 5.11 (1.09–25.11) | 0.92 (0.85–1.00) |
Total | 72 | 98 | 62 | 108 | ||||
Calcitonin
cut-off (pg/mL) |
N with Contralateral Lateral LNM | N without Contralateral Lateral LNM | Positive LR | Negative LR |
N with
Distant Metastasis |
N without
Distant Metastasis |
Positive LR | Negative LR |
20 | 0 | 22 | 1.16 (1.09–1.24) | 0 | 0 | 22 | 1.16 (1.09–1.23) | 0 |
100 | 0 | 44 | 1.40 (1.26–1.54) | 0 | 0 | 44 | 1.37 (1.25–1.51) | 0 |
200 | 0 | 62 | 1.66 (1.46–1.89) | 0 | 1 | 61 | 1.40 (1.05–1.87) | 0.33 (0.05–2.10) |
300 | 0 | 74 | 1.90 (1.64–2.21) | 0 | 1 | 73 | 1.59 (1.18–2.14) | 0.28 (0.04–1.75) |
400 | 2 | 83 | 1.83 (1.40–2.40) | 0.27 (0.07–0.98) | 1 | 84 | 1.82 (1.34–2.47) | 0.24 (0.04–1.52) |
500 | 2 | 90 | 2.03 (1.53–2.69) | 0.25 (0.07–0.90) | 1 | 91 | 2.00 (1.46–2.74) | 0.22 (0.04–1.40) |
1000 | 5 | 111 | 2.23 (1.40–3.54) | 0.50 (0.25–1.02) | 2 | 114 | 2.53 (1.59–4.03) | 0.36 (0.11–1.19) |
2000 | 7 | 127 | 2.69 (1.45–4.99) | 0.61 (0.36–1.04) | 3 | 131 | 3.27 (1.75–6.09) | 0.46 (0.19–1.14) |
3000 | 8 | 139 | 3.94 (1.85–8.35) | 0.64 (0.41–1.01) | 3 | 144 | 5.63 (2.82–11.23) | 0.42 (0.17–1.03) |
5000 | 8 | 144 | 5.57 (2.47–12.57) | 0.62 (0.39–0.98) | 3 | 149 | 7.81 (3.69–16.46) | 0.41 (0.17–1.00) |
7000 | 10 | 146 | 4.47 (1.60–12.39) | 0.76 (0.55–1.07) | 4 | 152 | 8.07 (3.24–20.26) | 0.53 (0.27–1.07) |
10,000 | 11 | 151 | 6.69 (1.78–25.10) | 0.81 (0.62–1.07) | 6 | 156 | 6.76 (1.61–28.33) | 0.78 (0.52–1.16) |
Total | 14 | 156 | 8 | 162 |
N = number of patients; LNM = lymph node metastasis; LR = likelihood ratio; Negative LR below 0.2 and Positive LR above 5 were marked in bolds number.